← Back to Search

Beta-lactamase Inhibitor

QPX7831 for Bacterial Infection

Phase 1
Waitlist Available
Research Sponsored by Qpex Biopharma, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 17 days
Awards & highlights

Study Summary

Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 17 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 17 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Area under the plasma concentration versus time curve (AUC) between cohorts
Incidence of Treatment -Emergent Adverse events by subject and by cohort (single dose, multiple doses)
Number of patients with changes from baseline in safety parameters
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: QPX7831 SAD CohortsExperimental Treatment2 Interventions
oral, single ascending dose (or placebo)
Group II: QPX7831 MAD CohortsExperimental Treatment2 Interventions
oral, multiple ascending dose (or placebo)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
QPX7831
2021
Completed Phase 1
~80
placebo comparator
2016
Completed Phase 4
~4390

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Qpex Biopharma, Inc.Lead Sponsor
6 Previous Clinical Trials
342 Total Patients Enrolled
Biomedical Advanced Research and Development AuthorityFED
79 Previous Clinical Trials
909,223 Total Patients Enrolled
Jeffery Loutit, MBChBStudy DirectorQpex Biopharma, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults
2021. "Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04578873.
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top